Recent advances in dairy ingredients and cardiovascular diseases with special reference to milk fat components

Dairy in Human Health and Disease across the Lifespan

Volumn , Issue , 2017, Pages 251-261

  Fontecha, Javier ^a   Juárez, Manuela ^a  

^a INSTITUTE OF FOOD SCIENCE RESEARCH CIAL   (Spain)

Author keywords

Bioactive peptides; Cardiovascular diseases; Conjugated linoleic acid (CLA); Full fat dairy; Milk minerals; Phospho and sphingolipids; Saturated fatty acids

Indexed keywords

EID: 85032159425     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-809868-4.00019-4     Document Type: Chapter

References (83)

1. Abd El-Salam M.H., El-Shibiny S. Formation and potential uses of milk proteins as nanodelivery vehicles for nutraceuticals: a review. Int. J. Dairy Technol. 2012, 65:13-21.
2. Alexander D.D., Bylsma L.C., Vargas A.J., Cohen S.S., Doucette A., Mohamed M., et al. Dairy consumption and CVD: a systematic review and meta-analysis. Br. J. Nutr. 2016, 115:737-750.
3. Alonso L., Fontecha J., Lozada L., Fraga M.J., Juárez M. Fatty acid composition of caprine milk: major, branched-chain, and trans fatty acids. J. Dairy Sci. 1999, 82:878-884.
4. Astrup A. Yogurt and dairy product consumption to prevent cardiometabolic diseases: epidemiologic and experimental studies. Am. J. Clin. Nutr. 2014, 99(Suppl.):1235S-1242S.
5. Astrup A. A changing view on saturated fatty acids and dairy: from enemy to friend. Am. J. Clin. Nutr. 2014, 100:1407-1408.
6. Carmena R. La grasa de la dieta y el riesgo cardiovascular. Aliment. Nutr. Salud (ANS) 2016, 23:1-3.
7. Castro-Gómez P., Garcia-Serrano A., Visioli F., Fontecha J. Relevance of dietary glycerophospholipids and sphingolipids to human health. Prostaglandins Leukot. Essent. Fatty Acids 2015, 101:41-51.
8. Castro-Gómez P., Rodríguez-Alcalá L.M., Monteiro K.M., Ruiz A.L., Carvalho J.E., Fontecha J. Antiproliferative activity of buttermilk lipid fractions isolated using food grade and non-food grade solvents on human cancer cell lines. Food Chem. 2016, 212:695-702.
9. Chardigny J.M., Destaillats F., Malpuech-Brugère C., Moulin J., Bauman D.E., Lock A.L. Do industrially-produced and natural trans fatty acid sources have the same impact on cardiovascular diseases risk factors in healthy subjects? Results of the TRANSFACT Study. Am. J. Clin. Nutr. 2008, 87:558-566.
10. Choi J., Sabikhi L., Hassan A., Anand S. Bioactive peptides in dairy products. Int. J. Dairy Technol. 2012, 65:1-12.
11. Chowdhury R., Warnakula S., Kunutsor S., Crowe F., Ward H.A., Johnson L., et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann. Intern. Med. 2014, 160:398-406.
12. Contarini G., Povolo M. Phospholipids in milk fat: composition, biological and technological significance, and analytical strategies. Int. J. Mol. Sci. 2013, 14:2808-2831.
13. Conway V., Gauthier S.F., Pouliot Y. Buttermilk: much more than a source of milk phospholipids. Anim. Front. 2014, 4:44-51.
14. De Souza R.J., Mente A., Maroleanu A., Cozma A.I., Ha V., Kishibe T., et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. Br. Med. J. 2015, 351:h3978.
15. Dror D.K., Allen L.H. Dairy product intake in children and adolescents in developed countries: trends, nutritional contribution, and a review of association with health outcomes. Nutr. Rev. 2014, 72:68-81.
16. Elwood P.C., Pickering J.E., Givens D.I., Gallacher J.E. The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids 2010, 45:925-939.
17. Fontecha J., Rodriguez-Alcalá L.M., Calvo M.V., Juárez M. Bioactive milk lipids. Curr. Nutr. Food Sci. 2011, 7:155-159.
18. Gayet-Boyer C., Tenenhaus-Aziza F., Prunet C., Marmonier C., Malpuech-Brugère C., Lamarche L., et al. Is there a linear relationship between the dose of ruminant trans-fatty acids and cardiovascular risk markers in healthy subjects: results from a systematic review and meta-regression of randomised clinical trials. Br. J. Nutr. 2014, 112:1914-1922.
19. Gebauer S.K., Destaillats F., Mouloungui Z., Candy L., Bezelgues J.B., Dionisi F., et al. Effect of trans fatty acid isomers from ruminant sources on risk factors of cardiovascular disease: study design and rationale. Cont. Clin. Trials 2011, 32:569-576.
20. Givens D.I. Food chain and health milk in the diet: good or bad for vascular disease?. Proc. Nutr. Soc. 2012, 71:98-104.
21. Goudjil H., Fontecha J., Luna P., De la Fuente M.A., Alonso L., Juárez M. Quantitative characterization of unsaturated and trans fatty acids in ewe's milk fat. Lait 2004, 84:473-482.
22. Hall W.L., Millward D.J., Long S.J., Morgan L.M. Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br. J. Nutr. 2003, 89:239-248.
23. Heaney R.P. Calcium, dairy products and osteoporosis. J. Am. Coll. Nutr. 2000, 19:83S-99S.
24. Heaney R.P., Davies K.M., Barger-Luxa M.J. Calcium and weight: clinical studies. J. Am. Coll. Nutr. 2002, 21:152S-155S.
25. Hernández-Ledesma B., García-Nebot M.J., Fernández-Tomé S., Amigo L., Recio I. Dairy protein hydrolysates: peptides for health benefits. Int. Dairy J. 2014, 38:82-100.
26. Hess J.M., Jonnalagadda S.S., Slavin J.L. Dairy foods: current evidence of their effects on bone, cardiometabolic, cognitive, and digestive health. Compr. Rev. Food Sci. Food Saf. 2016, 15:251-268.
27. IDF-International Dairy Federation The Health Benefits of Milk and Dairy Products 2007, Bulletin International Dairy Federation, 417, Brussels, Belgium.
28. Institute of Medicine Dietary Reference Intakes for Protein and Amino Acids 2005, National Press, Washington, DC.
29. Jacome-Sosa M.M., Vacca C., Mangat R., Diane A., Nelson R.C., Reaney M.J., et al. Diets enriched in trans-11 vaccenic acid alleviate ectopic lipid accumulation and metabolic syndrome. J. Nutr. Biochem. 2014, 25:692-701.
30. Jensen R.G. The composition of bovine milk lipids: January 1995 to December 2000. J. Dairy Sci. 2002, 85:295-350.
31. Juárez M., De la Fuente M.A., Fontecha J. Los nutrientes de la leche en la salud cardiovascular. Nutr. Hosp. 2015, 31:26-32.
32. Kim J.H. Conjugated linoleic acid: potential health benefits as a functional food ingredient. Ann. Rev. Food Sci. Technol. 2016, 7:221-244.
33. Kim J.H., Kim Y.J., Park Y. Conjugated linoleic acid and postmenopausal women's health. J. Food Sci. 2015, 80:1137-1143.
34. Küllenberg D., Taylor L.A., Schneider M., Massing U. Health effects of dietary phospholipids. Lipids Health Dis. 2012, 11:1-16.
35. Legrand, P., 2011. Nutritional Interest of Dairy Fat. IDF World Dairy Summit.
36. Lim J.N., Oh J.J., Wang T., Lee J.S., Kim S.H., Kim Y.J., et al. Trans-11 18:1 vaccenic acid has a direct anti-carcinogenic effect on MCF-7 human mammary adenocarcinoma cells. Nutrients 2014, 6:627-636.
37. Lorenzen J.K., Jensen S.K., Astrup A. Milk minerals modify the effect of fat intake on serum lipid profile: results from an animal and a human short-term study. Br. J. Nutr. 2014, 111:1412-1420.
38. Lovegrove J.A., Hobbs D.A. Plenary Lecture 2: Milk and dairy produce and CVD: new perspectives on dairy and cardiovascular health. Proc. Nutr. Soc. 2016, 24:1-12.
39. Luhovyy B.L., Akhavan T., Anderson G.H. Whey proteins in the regulation of food intake and satiety. J. Am. Coll. Nutr. 2007, 26:704S-712S.
40. Markey O., Vasilopoulou D., Givens D.I., Lovegrove J.A. Dairy and cardiovascular health: friend or foe?. Nutr. Bull. 2014, 39:161-171.
41. Martínez-Marín A.L., Gómez-Cortés P., Gómez-Castro G., Juárez M., Pérez-Alba L., Pérez-Hernández M., et al. Animal performance and milk fatty acid profile of dairy goats fed diets added differently unsaturated plant oils on fatty acid profile of goat milk. J. Dairy Sci. 2011, 94:5359-5368.
42. McClean S., Beggs L.B., Welch R.W. Antimicrobial activity of antihypertensive food-derived peptides and selected alanine analogues. Food Chem. 2014, 146:443-447.
43. Mensink R.P. Effects of stearic acid on plasma lipid and lipoproteins in humans. Lipids 2005, 40:1201-1205.
44. Mensink R.P., Katan M.B. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. New Engl. J. Med. 1990, 323:439-445.
45. Moreno L.A., Bel-Serrat S., Santaliestra-Pasías A., Bueno G. Dairy products, yogurt consumption, and cardiometabolic risk in children and adolescents. Nutr. Rev. 2015, 73:8-14.
46. Mozaffarian D. Natural trans fat, dairy fat, partially hydrogenated oils, and cardiometabolic health: the Ludwigshafen Risk and Cardiovascular Health Study. Eur. Heart J. 2015, 37:1079-1081.
47. Mozaffarian D., De Oliveira Otto M.C., Lemaitre R.N., Fretts A.M., Hotamisligil G., Tsai M.Y., et al. Trans-palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Am. J. Clin. Nutr. 2013, 97:854-861.
48. Nagpal R., Behare P.V., Kumar M., Mohania D., Yadav M., Jain S., et al. Milk, milk products, and disease free health: an updated overview. Crit. Rev. Food Sci. Nutr. 2012, 52:321-333.
49. Nestel P. Trans fatty acids: are its cardiovascular risks fully appreciated?. Clin. Ther. 2014, 36:315-321.
50. Nilsen R., Pripp A.H., Høstmark A.T., Haug A., Skeie S. Is consumption of a cheese rich in angiotensin-converting enzyme-inhibiting peptides, such as the Norwegian cheese Gamalost, associated with reduced blood pressure?. J. Dairy Sci. 2014, 97:2662-2668.
51. O'Sullivan T.A., Bremner A.P., Mori T.A., Beilin L.J., Wilson C., Hafekost K., et al. Regular and reduced fat dairy products show similar associations with markers of adolescent cardiometabolic health. Nutrients 2016, 8(22):1-16.
52. Pal S., Ellis V. The chronic effects of whey proteins on blood pressure, vascular function, and inflammatory markers in overweight individuals. Obesity 2010, 18:1354-1359.
53. Pal S., Radavelli-Bagatini S. Etiology and pathophysiology/obesity comorbidities. The effects of whey protein on cardiometabolic risk factors. Obes. Rev. 2013, 14:324-343.
54. Park Y.W., Nam M.S. Bioactive peptides in milk and dairy products: a review. Korean J. Food Sci. Anim. Resour. 2015, 35:831-840.
55. Parodi P.W. Milk fat in human nutrition. Aust. J. Dairy Technol. 2004, 59:3-59.
56. Parodi P.W. Nutritional significance of milk lipids. Advanced Dairy Chemistry, Vol 2, Lipids 2006, 601-639. Springer, USA. third ed. P.F. Fox, P.L.H. McSweeney (Eds.).
57. Parodi P.W. Milk lipids: their role as potential anti-cancer agents. Sci. Aliments 2009, 28:44-52.
58. Patterson E., Larsson S.C., Wolk A., Åkesson A. Association between dairy food consumption and risk of myocardial infarction in women differs by type of dairy food. J. Nutr. 2013, 143:74-79.
59. Phelan M., Kerins D. The potential role of milk-derived peptides in cardiovascular disease. Food Funct. 2011, 2:153-167.
60. Pisanu S., Ghisaura S., Pagnozzi D., Falchi G., Biosa G., Tanca A., et al. Characterization of sheep milk fat globule proteins by two-dimensional polyacrylamide gel electrophoresis/mass spectrometry and generation of a reference map. Int. Dairy J. 2012, 24:76-86.
61. Praagman J., Franco O.H., Ikram M.A., Soedamah-Muthu S.S., Engberink M.F., van Rooij F.J.A., et al. Dairy products and the risk of stroke and coronary heart disease: the Rotterdam Study. Eur. J. Nutr. 2015, 54:981-990.
62. Pripp A.H. Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials. Food Nutr. Res. 2008, 52:1-9.
63. Qin L.Q., Xu J.Y., Dong J.Y., Zhao Y., van Bladeren P., Zhang P.W. Lactotripeptides intake and blood pressure management: a meta-analysis of randomised controlled clinical trials. Nutr. Metab. Cardiovasc. Dis. 2013, 23:395-402.
64. Qin L.Q., Xu J.Y., Han S.F., Zhang Z.L., Zhao Y.Y., Szeto I.M.Y. Dairy consumption and risk of cardiovascular disease: an updated meta-analysis of prospective cohort studies. Asia Pac. J. Clin. Nutr. 2015, 24:90-100.
65. Ralston R.A., Lee J.H., Truby H., Palermo C.E., Walker K.Z. A systematic review and meta-analysis of elevated blood pressure and consumption of dairy foods. J. Clin. Hypertens. 2012, 26:3-13.
66. Ran-Ressler R.R., Bae S.E., Lawrence P., Wang D.H., Brenna J.T. Branched-chain fatty acid content of foods and estimated intake in the USA. Br. J. Nutr. 2014, 112:565-572.
67. Ratnayake W.M.N. Concerns about the use of 15:0, 17:0, and trans-16:1n-7 as biomarkers of dairy fat intake in recent observational studies that suggest beneficial effects of dairy food on incidence of diabetes and stroke. Am. J. Clin. Nutr. 2015, 101:1102-1103.
68. Rogelj I. Milk, dairy products, nutrition and health. Food Technol. Biotechnol. 2000, 38:143-147.
69. Samara A., Herbeth B., Ndiaye N.C., Fumeron F., Billod S., Siest G., et al. Dairy product consumption, calcium intakes, and metabolic syndrome-related factors over 5 years in the STANISLAS study. Nutrition 2013, 29:519-524.
70. Santaren I.D., Watkins S.M., Liese A.D., Wagenknecht L.E., Rewers M.J., Haffner S.M., et al. Serum pentadecanoic acid (15:0), a short-term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders. Am. J. Clin. Nutr. 2014, 100:1532-1540.
71. Soedamah-Muthu S.S., Ding E.L., Al-Delaimy W.K., Hu F.B., Engberink M.F., Willett W.C., et al. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 2011, 93:158-171.
72. Soedamah-Muthu S.S., Verberne L.D.M., Ding E.L., Engberink M.F., Geleijnse J.M. Dairy consumption and incidence of hypertension a dose-response meta-analysis of prospective cohort studies. Hypertension 2012, 60:1131-1137.
73. Soerensen K.V., Thorning T.K., Astrup A., Kristensen M., Lorenzen J.K. Effect of dairy calcium from cheese and milk on fecal fat excretion, blood lipids, and appetite in young men. Am. J. Clin. Nutr. 2014, 99:984-991.
74. Sun Y., Jiang C.H., Cheng K.K., Zhang W., Leung G.M., Lam T.H., et al. Milk consumption and cardiovascular risk factors in older Chinese: The Guangzhou Biobank Cohort Study. PLoS One 2014, 9:1-8.
75. Tome, D., 2011. Latest Scientific Developments on Protein Nutrition and Dairy Protein. IDF World Dairy Summit.
76. Tunick M.H., Van Hekken D.L. Dairy products and health: recent insights. J. Agric. Food Chem. 2015, 63:9381-9388.
77. Vlaeminck B., Fievez V., Cabrita A.R.J., Fonseca A.J.M., Dewhurst R.J. Factors affecting odd- and branched-chain fatty acids in milk: a review. Anim. Feed Sci. Technol. 2006, 131:389-417.
78. Wu Z., Pan D., Zhen X., Cao J. Angiotensin I-converting enzyme inhibitory peptides derived from bovine casein. J. Sci. Food Agric. 2013, 93:1331-1337.
79. Xu J.Y., Qin L.Q., Wang P.Y., Li W., Chang C. Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition 2008, 24:933-940.
80. Yakoob M.Y., Shi P., Hu F.B., Campos H., Rexrode K.M., Orav E.J., et al. Circulating biomarkers of dairy fat and risk of incident stroke in U.S. men and women in 2 large prospective cohorts. Am. J. Clin. Nutr. 2014, 100:1437-1447.
81. Yang B., Chen H., Stanton C., Ross R.P., Zhang H., Chen Y.Q., et al. Review of the roles of conjugated linoleic acid in health and disease. J. Funct. Foods 2015, 15:314-325.
82. Yang B., Campbell P.T., Gapstur S.M., Jacobs E.J., Bostick R.M., Fedirko V., et al. Calcium intake and mortality from all causes, cancer, and cardiovascular disease: the Cancer Prevention Study II Nutrition Cohort. Am. J. Clin. Nutr. 2016, 103:886-894.
83. Yerlikaya O., Acu M., Kinik O. Importance of dairy products in cardiovascular diseases and type 2 diabetes. Crit. Rev. Food Sci. Nutr. 2013, 53:902-908.